November 10, 2026
Daily Health News: November 10, 2026
By Ryan Purakal
Three stories worth knowing today, and what they mean for you.
1. The FDA is adding a warning about a rare eye problem to GLP-1 drugs
On November 9, the FDA said it will require makers of GLP-1 medicines, the drug class that includes Ozempic, Wegovy, Mounjaro and Zepbound, to add a warning to their labels about a possible higher risk of an eye condition called NAION (nonarteritic anterior ischemic optic neuropathy). NAION happens when the optic nerve doesn't get enough blood, and it can cause vision loss, often in one eye. The change covers 12 approved drugs. It is a new warning, not a limit on who can use them.
The risk looks small. Across 126 clinical trials with 78,217 people taking a GLP-1, the FDA counted about 6 cases per 100,000 people per year, compared with about 4 per 100,000 for people taking a placebo or a different diabetes drug. Real-world data gave mixed results depending on which drug GLP-1s were compared with. The FDA says the benefits of these medicines still outweigh the risks when they are used as directed. Warning signs include sudden, painless vision loss in one eye, blind spots, blurry spots in the center of your vision, or colors that look off.
What to do: If you or someone in your family takes a GLP-1, don't stop it on your own; talk with the doctor or pharmacist about any questions. If sudden vision loss in one eye happens, contact a health care provider right away.
Sources: Healthline, BioSpace
2. Cuts to drug test strip funding are squeezing overdose prevention groups
In April, the federal Substance Abuse and Mental Health Services Administration (SAMHSA) told organizations they can no longer use its money to buy test strips that check drugs for fentanyl, xylazine and other dangerous additives. KFF Health News reported on what that looks like in North Carolina, where SAMHSA had been the state opioid response program's only source of money for fentanyl and xylazine strips. Nationally, the move is part of more than $300 million in federal cuts to overdose prevention and treatment funding.
Small groups are feeling it. In Greenville, 81-year-old Diannee Carden Glenn runs a volunteer group that lost a little over $15,000 a year in SAMHSA funding; she now pays for supplies with her Social Security, other retirement income and donations. Strips can cost $1 or more each, and her group hands out several hundred a week. A program serving Indigenous communities in North and South Carolina says it no longer has money for strips at all. A UNC lab that tests street drug samples has found about 500 different substances since 2022. A study in JAMA Network Open found that people who use test strips are more likely to use other safety steps, like carrying naloxone and not using alone.
What to do: If you think someone may be overdosing, call 911 right away. You can ask a pharmacist or school nurse about naloxone and how to use it. If you or someone you know is struggling, call or text 988 any time to reach the Suicide and Crisis Lifeline.
Source: KFF Health News via Yahoo News
3. A popular baby bottle sterilizer dryer is recalled because it can overheat
Baby Brezza is recalling about 29,000 SuperFast Sterilizer Dryers, a countertop machine that cleans and dries baby bottles and breast pump parts. The units can overheat and cause burns. The company has received 32 reports of the dryers overheating or melting their plastic case. No injuries have been reported.
The recall covers model numbers BRZ0083, BRZ0154 and BRZ0156, printed on the label on the bottom of the unit. They were sold from January 2024 through October 2026 at TJ Maxx and Marshalls stores nationwide and online at babybrezza.com, target.com and babylist.com, for $160 to $180.
What to do: If your family has one, unplug it and stop using it. Baby Brezza will send a free replacement: register at babybrezza.com, fill out the recall form, cut the power cord and upload photos. Questions go to 888-527-9824 (9 a.m. to 5 p.m. ET, Monday to Friday) or recall@babybrezza.com.
Source: FOX 9
Health Decoded's daily news roundup pulls from public reporting and puts it in plain language. It isn't medical, legal, or financial advice.